AI-powered decisions enable fully automated cell culture of organoids and iPSCs

Friday, October 3, 2025 at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT

While cell-based models and assays are basic tools for drug development and biological research, tissue culture remains the most routine, hands-on, and time-consuming part of biological studies. Because of protocol complexity, sensitivity to errors, and substantial training requirements, these processes are difficult to automate and to ensure reproducibility and quality, especially when working with complex cell models such as organoids.

In this webinar, Dr. Oksana Sirenko from Molecular Devices, will present an overview of how AI-powered decision-making and automation create a fully automated cell culture platform. Discover how automation can not only alleviate these time-sensitive and highly routine tasks from the scientist, but can also reduce human error and inconsistencies associated with manual processes.

Key learning objectives:

• Explore how automated cell culture can lead to more reproducible assay outcomes
• Discover how automated, AI-powered decision making enables the creation of fully walkaway workflows
• Learn how complex cell models such as organoids, including brain organoids, and iPSCs can be cultured

Who should attend?

• Core facility leaders or managers.
• Researchers interested in scaling up their 3D biology workflows.
• Researchers working in high-throughput screening, high-content screening, or toxicology workflows.

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.